@article {Kacprzak1031, author = {Aneta Kacprzak and Dorota Kowalczyk and Joanna Biernacka}, title = {Patients{\textquoteright} experience with and knowledge on clinical trials}, volume = {56}, number = {suppl 64}, elocation-id = {1031}, year = {2020}, doi = {10.1183/13993003.congress-2020.1031}, publisher = {European Respiratory Society}, abstract = {Introduction: Clinical trials (CTs) are crucial for development of new therapies and in many respiratory diseases they are the only opportunity for effective treatment. Many countries don{\textquoteright}t fully use potential and benefits CTs may offer. Low patients{\textquoteright} (pts) awareness may be partially responsible for this.Aim: To assess patients{\textquoteright} experience with and knowledge on CTs.Methods: 111 pts from chest medical units of a specialized thoracic centre completed anonymously and voluntarily the questionnaire containing 23 questions.Results: 57\% of pts stated they knew what CTs were, but majority of them declared only little knowledge on the subject. Only 9 pts had been ever offered participation in CT, 4 of them agreed to take part. Although 81\% of pts knew that CTs are mandatory for new medicines to be registered, majority of them were not familiar with concepts of informed consent, placebo use or pts{\textquoteright} rights. There was no relationship between level of knowledge and pts{\textquoteright} age, sex, education or disease type. The higher level of knowledge correlated with higher level of readiness for independent search for information on healthy issues and shorter duration of a disease. Also pts that had been offered part in CTs before, had better knowledge on the subject.Conclusions: Pts{\textquoteright} experience and knowledge on CTs were poor. That problem needs to be addressed in order to improve respiratory healthcare by better use of benefits CTs offer.FootnotesCite this article as: European Respiratory Journal 2020; 56: Suppl. 64, 1031.This abstract was presented at the 2020 ERS International Congress, in session {\textquotedblleft}Respiratory viruses in the "pre COVID-19" era{\textquotedblright}.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).}, issn = {0903-1936}, URL = {https://erj.ersjournals.com/content/56/suppl_64/1031}, eprint = {https://erj.ersjournals.com/content}, journal = {European Respiratory Journal} }